The combination of features from CXCR3+CD8+ T cells and CD11c+ antigen-presenting cells (APCs) was shown to be associated with OS and progression-free survival (PFS) in patients with HCC (68). This evidence concerns the gene CXCR3 and hepatocellular carcinoma.